Management of viral infections in solid organ transplant recipients (Q37892559)

24 August 2017

1 reference

title

Management of viral infections in solid organ transplant recipients (English)

1 reference

24 August 2017

Raymund R Razonable

1

1 reference

24 August 2017

publication date

1 June 2011

1 reference

Expert Review of Anti-infective Therapy

24 August 2017

published in

1 reference

24 August 2017

volume

9

1 reference

24 August 2017

issue

6

1 reference

24 August 2017

page(s)

685-700

1 reference

Transmission of lymphocytic choriomeningitis virus by organ transplantation

24 August 2017

cites work

1 reference

Transmission of rabies virus from an organ donor to four transplant recipients

21 January 2018

1 reference

Transmission of West Nile virus from an organ donor to four transplant recipients

21 January 2018

1 reference

Human herpesvirus 6 infections after liver transplantation

21 January 2018

1 reference

Outcome of liver transplantation for hepatitis B in the United States

21 January 2018

1 reference

A practical guide to the management of HCV infection following liver transplantation

21 January 2018

1 reference

The pathogenesis of hepatitis C virus is influenced by cytomegalovirus

21 January 2018

1 reference

Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.

21 January 2018

1 reference

Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation

21 January 2018

1 reference

Delayed-onset primary cytomegalovirus disease after liver transplantation

21 January 2018

1 reference

Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation

21 January 2018

1 reference

Primary cytomegalovirus disease after five years of antiviral prophylaxis

21 January 2018

1 reference

Clinical features and outcomes of delayed-onset primary cytomegalovirus disease in cardiac transplant recipients

21 January 2018

1 reference

Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes

21 January 2018

1 reference

Clinical features and outcomes of cytomegalovirus retinitis after transplantation

21 January 2018

1 reference

Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection

21 January 2018

1 reference

Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease

21 January 2018

1 reference

National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976-1994.

21 January 2018

1 reference

Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States

21 January 2018

1 reference

A comparative study of herpes simplex infections in renal transplant and leukemic patients

21 January 2018

1 reference

Transmission of infection with herpes simplex virus by renal transplantation

21 January 2018

1 reference

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

21 January 2018

1 reference

Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir

21 January 2018

1 reference

Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture

21 January 2018

1 reference

Clinical practice. Herpes zoster

21 January 2018

1 reference

Varicella zoster virus serostatus before and after kidney transplantation, and vaccination of adult kidney transplant candidates

21 January 2018

1 reference

Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era.

21 January 2018

1 reference

Interlaboratory comparison of epstein-barr virus viral load assays

21 January 2018

1 reference

Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir

21 January 2018

1 reference

Dynamics of Cytomegalovirus Replication during Preemptive Therapy with Oral Ganciclovir

21 January 2018

1 reference

Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients

21 January 2018

1 reference

Interlaboratory comparison of cytomegalovirus viral load assays.

21 January 2018

1 reference

Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials.

21 January 2018

1 reference

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

21 January 2018

1 reference

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

21 January 2018

1 reference

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

21 January 2018

1 reference

The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients

21 January 2018

1 reference

Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial

21 January 2018

1 reference

Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients

21 January 2018

1 reference

Immune-based therapies for cytomegalovirus infection

21 January 2018

1 reference

The impact of human herpesvirus-6 and -7 infection on the outcome of liver transplantation

21 January 2018

1 reference

21 January 2018

1 reference

Sirolimus for Kaposi's sarcoma.

21 January 2018

1 reference

Sirolimus for Kaposi's sarcoma in renal-transplant recipients

21 January 2018

1 reference

Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations

21 January 2018

1 reference

Polyomavirus BK nephropathy: a (re-)emerging complication in renal transplantation

21 January 2018

1 reference

Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors

21 January 2018

1 reference

Progressive multifocal leukoencephalopathy in transplant recipients

21 January 2018

1 reference

The decade of polyomavirus BK-associated nephropathy: state of affairs

21 January 2018

1 reference

Role of human polyomaviruses in respiratory tract disease in young children

21 January 2018

1 reference

Prevalence and pathogenicity of WU and KI polyomaviruses in children, the Netherlands

21 January 2018

1 reference

Identification of a novel polyomavirus from patients with acute respiratory tract infections

21 January 2018

1 reference

21 January 2018

1 reference

Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia

21 January 2018

1 reference

Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study

21 January 2018

1 reference

Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation

21 January 2018

1 reference

Antivirals for the treatment of polyomavirus BK replication

21 January 2018

1 reference

Hepatitis E virus and chronic hepatitis in organ-transplant recipients

21 January 2018

1 reference

Chronic hepatitis E virus infection in liver transplant recipients

21 January 2018

1 reference

Lamivudine for patients with chronic hepatitis B and advanced liver disease

21 January 2018

1 reference

Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation

21 January 2018

1 reference

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin

21 January 2018

1 reference

Combined lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation: long-term results

21 January 2018

1 reference

Hepatitis B and liver transplantation: 2008 update

21 January 2018

1 reference

Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy

21 January 2018

1 reference

Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation

21 January 2018

1 reference

Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.

21 January 2018

1 reference

Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation

21 January 2018

1 reference

Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus

21 January 2018

1 reference

Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C.

21 January 2018

1 reference

Peginterferon alfa-2a for hepatitis C after liver transplantation: two randomized, controlled trials

21 January 2018

1 reference

Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.

21 January 2018

1 reference

Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin.

21 January 2018

1 reference

Severe pneumonia and human bocavirus in adult

21 January 2018

1 reference

Severe Acute Respiratory Syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening

21 January 2018

1 reference

Respiratory viruses and chronic rejection in lung transplant recipients.

21 January 2018

1 reference

Diagnosis and epidemiology of community-acquired respiratory virus infections in the immunocompromised host

21 January 2018

1 reference

Active surveillance for respiratory virus infections in adults who have undergone bone marrow and peripheral blood stem cell transplantation.

21 January 2018

1 reference

Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study

21 January 2018

1 reference

The pathogenesis and management of influenza virus infection in organ transplant recipients

21 January 2018

1 reference

Influenza virus infection in adult solid organ transplant recipients

21 January 2018

1 reference

Influenza vaccination is efficacious and safe in renal transplant recipients

21 January 2018

1 reference

Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study.

21 January 2018

1 reference

Vaccinations for Adult Solid-Organ Transplant Recipients: Current Recommendations and Protocols

21 January 2018

1 reference

Outcome of influenza infection managed with oseltamivir in lung transplant recipients

21 January 2018

1 reference

Neuraminidase inhibitors for influenza

21 January 2018

1 reference

Recovery of drug-resistant influenza virus from immunocompromised patients: a case series

21 January 2018

1 reference

Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors

21 January 2018

1 reference

Use of Oseltamivir to control influenza complications after bone marrow transplantation

21 January 2018

1 reference

John F. Enders lecture 2006: antivirals for influenza

21 January 2018

1 reference

Community respiratory viral infection in adult lung transplant recipients

21 January 2018

1 reference

Molecular epidemiology of outbreak of respiratory syncytial virus within bone marrow transplantation unit

21 January 2018

1 reference

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

21 January 2018

1 reference

Palivizumab prophylaxis to prevent respiratory syncytial virus mortality after pediatric bone marrow transplantation: a decision analysis model.

21 January 2018

1 reference

Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection

21 January 2018

1 reference

Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation

21 January 2018

1 reference

Adenovirus infection in adult orthotopic liver transplant recipients: incidence and clinical significance.

21 January 2018

1 reference

Adenovirus Infection in Pediatric Liver Transplant Recipients

21 January 2018

1 reference

Adenovirus infection in pediatric small bowel transplantation recipients

21 January 2018

1 reference

A surveillance study of adenovirus infection in adult solid organ transplant recipients

21 January 2018

1 reference

Adenovirus in solid organ transplant recipients.

21 January 2018

1 reference

Adenovirus infection and treatment with cidofovir in children after liver transplantation

21 January 2018

1 reference

Successful cidofovir treatment in an adult heart transplant recipient with severe adenovirus pneumonia

21 January 2018

1 reference

Herpes Simplex Virus Infections in Solid Organ Transplant Recipients

21 January 2018

1 reference

Adoptive cell therapy against EBV-related malignancies: a survey of clinical results

21 January 2018

1 reference

Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

21 January 2018

1 reference

Viral Hepatitis in Solid Organ Transplant Recipients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERI.11.43

1 reference

24 August 2017

1 reference